Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1030, 2004-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA addresses postmarketing drug surveillance concerns
Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. :
Access to resources
Recommend
Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
By Gex-Fabry M.
Drug Safety, Vol. 24, Iss. 13, 2001-01 ,pp. :
Update on the Office of Drug Safety at the US FDA
Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. :
US FDA reports new steps in drug safety
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :